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Abstract 
This study sought to identify stigma differences between HIV/AIDS and other sexually 
transmitted infections (STIs).  Interviewees from Alabama, USA (n=537) rated two types of 
stigma (damage to social reputation and “moral weakness”) for seven infections ranging from 
“nuisance” conditions (e.g., pubic lice) to life-threatening disease (e.g., HIV/AIDS).  When 
asked which of the seven STIs would be most damaging to reputation, 74.8% of respondents 
chose HIV/AIDS.  However, when asked to choose which STI represented moral weakness in 
infected persons, HIV/AIDS was rated as significantly lower than the other STIs, which suggests 
that HIV/AIDS is perceived differently than non-HIV STIs.  This study addresses the possibility 
that advances in public awareness of HIV/AIDS have not necessarily been extrapolated into 
awareness of other STIs.  Clinicians should be aware of these high levels of stigma as potential 
barriers to treatment for all STIs.  Public health officials should consider the impact of 
undifferentiated stigma on STI prevention messages.  
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Introduction 
Sexually transmitted infections (STIs) have been stigmatized since syphilis was 
associated with sin and moral laxity in 14th century Europe.1     Until modern times, STIs were 
known collectively as venereal diseases with undifferentiated stigma because many infections 
were unrecognized or poorly defined.2   In the AIDS era, HIV stigma is widely considered to be 
distinct from and more severe than other STIs.3    However, the stigma of non-HIV STIs still 
exists and is blamed for a host of problems, including delayed treatment and increased morbidity 
from common infections.4  Differences between non-HIV and HIV stigma have yet to be 
examined fully, although work by Fortenberry et al. (2002; 2004) and others have begun to 
address this issue in clinical settings.5,6  In their study of community-based stigma, Lichtenstein, 
Neal, and Brodsky (2008) identified higher levels of HIV stigma compared to other STIs, but 
found that these “lesser” infections attracted substantial stigma as well. 7   In that study, non-HIV 
STIs were all considered to be a sign of sexual immorality regardless of the perceived 
seriousness of the disease.  This result is perhaps unexpected given that most STIs are curable or 
highly treatable and are among the most frequently reported diseases in the United States. 4  
 The present study examined differences in relation to stigma for HIV/AIDS and non-HIV 
STIs among a community sample in a southern U.S. state, the region with the highest HIV/STI 
rate in the U.S.8  We used two stigma constructs from Goffman’s (1963) theory on stigma: 
damage to social reputation (a social attribution, often based on group stigma) and attributions of 
moral weakness for afflicted individuals (an individual attribution for blame, broadly defined in 
terms of a deficient personal trait).9  These theoretical constructs have been applied to numerous 
studies on disability, and on mental and physical illness including for STIs.10,11,12  Clinical 
studies typically differentiate between group and individual stigma in describing barriers to 
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partner notification and treatment for STIs.5,6  In Lichtenstein, Hook, & Sharma’s (2005) 
community survey, respondents were unlikely to notify their sexual partners if they feared being 
labeled as immoral or sexually deviant.13  They were also likely to delay or avoid treatment for 
fear of being classified as members of a stigmatized group (e.g., STI clinic attendees).  For the 
present study, the two constructs were operationalized in items about damaged reputation and 
moral weakness of character for seven infections ranging from least serious (pubic lice) to most 
serious (HIV/AIDS). We hypothesized that stigma differences would occur for the selected STIs 
based on perceived seriousness in social or clinical realms. 
Method 
Participants 
The respondents (n=537) were predominantly white (78%) and female (63%) with a 
mean age of 52.6 years. Forty-six percent of respondents were unemployed; the retired 30% of 
respondents were counted as unemployed.  Fifty-eight percent of respondents were married, 85% 
had at least a high school education, and 69% lived in an urban area.  Ninety-six percent of 
respondents reported a religious affiliation (79% self-identified as Protestant).  Elderly persons, 
women, and whites were over-represented compared to the general population. This artifact is 
common in RDD surveys.14 
Procedure 
A random-digit-dialed (RDD) telephone survey asked adults in Alabama, USA, about 
stigma attributions for HIV and other STIs.  The research was approved by the University of 
Alabama Institutional Review Board. The survey was embedded in a larger yearly omnibus 
survey of attitudes held among citizens who were representative of the state. The questions were 
asked by staff at the Institute of Social Science Research at the University of Alabama who were 
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blind to the purposes of the study.  After successful contact was made, respondents were 
informed that they would be asked three questions about sexually transmitted diseases.  Thirty-
five respondents (6%) spontaneously objected to the topic and did not complete the survey.  The 
respondents who agreed to participate were then asked to rank the stigma of seven types of 
infection: pubic lice, gonorrhea, syphilis, chlamydia, genital warts, genital herpes, and 
HIV/AIDS.   Our response rate was 93.9% of surveys completed, which yielded 537 respondents 
for the final sample.    
The survey items were developed from the two stigma constructs: “damage to social 
reputation” and “weak moral character.”  The survey questions were posed as follows.    
1.   Respondents were asked to identify which STI would be most damaging to 
someone’s social reputation by choosing one of eight items. Options were genital 
herpes, gonorrhea/clap, HIV/AIDS, genital warts, syphilis, pubic lice/crabs, 
chlamydia, don’t know/ other.   
2. The respondents were then asked which STI was the second most likely to 
damage social reputation by choosing one of the remaining seven options listed in 
question 1. 
3. The third item took the form of a set of questions that asked respondents to rate 
each STI on a scale of 1 to 5 for the weak moral character construct, with 1 being 
“do not agree” and 5 being “strongly agree” for each STI. 
Results 
 For the first question, 74.8% of respondents reported that HIV/AIDS would be the most 
damaging to somebody’s reputation.  This response was significantly higher than for any other 
choice, with genital herpes (3%) ranked a distant second.   For the second question, 26.4% of 
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respondents identified genital herpes as the next most stigmatizing infection.  Again, this 
response was significantly higher than for any other choice, with syphilis (17.3%) ranked after 
genital herpes.   For both the first and second choice options, the responses for chlamydia, 
genital warts, and pubic lice ranked well below the responses for HIV/AIDS  (Table 1).  
- INSERT TABLE 1 ABOUT HERE -  
Results for the weak moral character sequence of stigma questions were analyzed through 
paired-samples t-tests.  Agreement with the 5-point Likert-type scale is presented with means 
and standard deviations for each STI (Table 2).  The options ranged from 1 (“strongly disagree 
that [STI] is a sign of a weak character”) to 5 (“strongly agree”).   
As opposed to the results for items 1 and 2, responses to item 3 indicated that HIV/AIDS 
had the lowest mean score for any infection.  Thus, acquiring HIV/AIDS was perceived to be less 
blameworthy in terms of individual moral character traits than other STIs.  The mean for 
HIV/AIDS was significantly lower than the means for gonorrhea (t[536] = 2.038, p = .042), 
syphilis (t[536] = 2.549, p = .011), pubic lice (t[536] = 3.485, p = .001), and chlamydia (t[536] = 
7.245, p <.001).  In turn, the mean score for chlamydia was significantly higher than the means 
for pubic lice (t[536] = 4.571, p<.001), syphilis (t[536] = 6.104, p<.001), gonorrhea (t[536] = 
6.387, p <.001), genital herpes (t[536] = 6.71, p <.001), genital warts (t[536] = 7.103, p<.001), 
and HIV/AIDS.  Nevertheless, the mean scores in this section ranged from a high of 3.72 for 
chlamydia to a low of 3.72 for HIV/AIDS, indicating moderately high stigma for all STIs in 
terms of blame for being infected (Table 2).  
- INSERT TABLE TWO ABOUT HERE – 
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Discussion 
These results help to differentiate between STI and HIV stigma as perceived by a 
representative sample of residents in a southern US state. HIV/AIDS was rated significantly 
more likely to damage someone’s social reputation than the other infections. However, 
HIV/AIDS attracted the least stigma for the weak moral character items compared to other STIs.  
This paradox illustrates how HIV/AIDS is understood differently from other STIs, and might be 
explained by social desirability bias.15   In this bias, respondents correct for attitudes they know to 
be unpopular, or their responses reflect media influences that frame HIV-positive people as 
sympathetic victims16 (e.g., in the case of “AIDS victims” in sub-Saharan Africa).  The 
dichotomy identified here suggests that non HIV-STIs may be viewed as merely “nasty.”  By 
contrast, HIV stigma has eased over time, with fear-based punitiveness towards HIV-positive 
people declining substantially in recent years.17    
The finding that attributions of blame in the “weak moral character” section were 
moderately high for all STIs is meaningful because personally experienced stigma is a barrier to 
care-seeking.6 This convergence suggests that stigma is relatively consistent for all STIs included 
in this study regardless of the seriousness of the infection.7 Nevertheless, caution should be taken 
in interpreting the results. In the case of STI stigma, respondents may lack sufficient knowledge 
about the “lesser” infections to know how to rank each condition in terms of relative stigma.  As 
noted in Table 1, 10.7% and 19.2% of respondents to items 1 and 2 answered “don’t know” or 
“refused” for the stigma rankings. These non-responses indicate that some respondents may have 
been unable to distinguish between different STIs or found the ranking process to be unpleasant, 
itself a possible reflection of stigma attributions.   If the sample refused to answer because of 
inability to distinguish between STIs, then this deficit raises the issue of the role of stigma in lack 
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of knowledge about infections that range from the merely irritating (pubic lice) to life-
threatening (syphilis and HIV/AIDS).  
The results of this study have implications for prevention and treatment in the southern 
US.  If common STIs are more likely than HIV/AIDS to attract stigma because of attributions of 
individual blame, then even minor infections might result in delays and non-treatment, which 
clearly has implications for prevention. The heightened stigma for minor STIs may be implicated 
in the high burden of STIs in the United States, especially if lack of awareness about different 
STIs results in widespread avoidance of screening and treatment.4  Clinicians should be aware of 
this relatively undifferentiated stigma, at least in Alabama, USA, and of the possibility that 
patients will refuse to disclose symptoms for fear of stigma, even when the infection is minor or 
highly curable. Further research should determine whether these findings are applicable to other 
regions.  If so, treatment and prevention efforts should be tailored accordingly.   
On a final note, our results suggest that prevention messages, particularly in the southern 
US, should target all STIs rather than target HIV risk alone.  Such messages would take account 
of the knowledge that non-HIV STIs are substantially more prevalent than HIV/AIDS in the 
United States and other western nations, and that stigma is a relatively unitary construct as 
measured in Alabama that impedes the reduction of both HIV/AIDS and non-HIV STIs.   
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TABLE 1 
 
Percentage Responses for STIs as Damaging to Reputation (n=537)  
______________________________________________________________________________ 
 
First choice   (%)1   Second choice  (%)1    
______________________________________________________________________________ 
 
HIV/AIDS   78.0   Genital Herpes 26.4 
Genital Herpes  3.0   Syphilis  17.3  
Syphilis   2.8   Gonorrhea  9.8   
Gonorrhea   1.2   HIV/AIDS  2.6   
Genital Warts   no data  Chlamydia  2.3    
Chlamydia   no data  Genital Warts  0.5   
Pubic Lice   no data  Pubic Lice  0.2  
______________________________________________________________________________ 
1. These totals do not add up to 100%. For first choice, 10.7% did not know/respond. For second choice, 
19.2% did not know/ respond. Overall, 6% of respondents spontaneously objected to the topic.   
 
 
                                         Stigma in HIV/AIDS and other STIs      Page 13 of 14 
 
TABLE 2 
 
Means and Standard Deviations for STIs as Sign of Weak Character 
______________________________________________________________________________ 
 
Item     Mean    Standard Deviation 
______________________________________________________________________________ 
 
Chlamydia    3.72    2.21 
Pubic Lice    3.32    1.85 
Syphilis    3.22    1.79 
Gonorrhea    3.19    1.76 
Genital Herpes   3.15    1.76 
Genital Warts    3.10    1.88 
HIV/AIDS    3.06    1.72 
______________________________________________________________________________ 
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